Factoring Equity into Benefit-Cost Analysis
Distributional weighting shows how benefit-cost analysis can be improved.
Flipping the Mission of Regulatory Review
President Biden’s memo could transform the mission of regulatory review by expanding OIRA’s role.
Regulatory Review Reimagined
Scholars discuss President Biden’s executive order that seeks to modernize the regulatory review process.
Recognizing the Losers in Benefit-Cost Analysis
Policymakers should consider direct compensation for people who regulations negatively affect.
A Decade of Political Swings, and Consistency
Presidential administrations have taken dramatically different approaches to regulation over the last ten years.
Analyzing COVID-19 Policymaking
Experts assess the use of VSLs and benefit-cost analysis for pandemic decision-making.
COVID-19 and Uncertainties in the Value Per Statistical Life
Uncertainties in value per statistical life estimates impact the extent to which COVID-19 policies yield net benefits.
Rethinking Benefit-Cost Analysis for COVID-19
The normative foundations of the value of statistical life render it an insufficient tool to analyze pandemic-related policies.